EVGN
EVGN
NASDAQ · Biotechnology

Evogene Ltd

$1.08
-0.02 (-1.82%)
As of Feb 8, 2:29 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.93M 3.80M 4.24M
Net Income 750.9K 985.2K 805.1K
EPS
Profit Margin 19.1% 25.9% 19.0%
Rev Growth -2.1% +24.5% -6.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.21M 3.82M 3.96M
Total Equity 3.81M 3.81M 3.70M
D/E Ratio 0.84 1.00 1.07
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.30M 1.34M 1.32M
Free Cash Flow 898.9K 1.13M 1.05M